New chief for 'jewel in the crown' of AgTech
By Kristy Dorsey
Stay updated with breaking news from Roslin Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy. By clicking on the "Accept & Close" button, you provide your explicit consent to the processing of your data to achieve the above goal. You can withdraw your consent using the method specified in the Privacy Po...
Two of the companies are based in the Scottish capital (Jane Barlow/PA) Sign up for our daily newsletter featuring the top stories from The Press and Journal. Thank you for signing up to The Press and Journal newsletter. Something went wrong - please try again later. Sign Up Four Scottish companies are set to achieve valuations of more than one billion dollars (£707 million), according to new analysis. Amphista Therapeutics in Motherwell, Roslin Technologies in Edinburgh, Interactive Investor in Glasgow and NuCana BioMed in Edinburgh have been identified as fast-growing companies whic...
Private companies are getting bigger amid the trend to de-equitisation, where growth companies are shunning public stock markets in their earlier and...
Feb 23, 2021 Vetsina Animal Diagnostics is seeking investment partners to commercialize its microRNA-based diagnostic tests for the animal health market. Vetsina, formed last year as a joint venture between Roslin Technologies and Destina Genomics, and initially focused on detecting microRNA biomarkers for infections, illnesses and disease in animals. It is on target to launch its first product in Q3 this year, with subsequent launches scheduled in 2022. Chief executive Dr. Simon Wheeler says initially the company plans to work through distribution partners in the U.K., then further afield...